Morrisons Announces Plans to Close Approximately 100 Stores Amid Government Cost Pressures Hengli Group Faces Sanctions Chinas SilktoPetrochemicals Empire Confronts US Pressure Standard Chartered to Trim Over 15 of Corporate Functions Roles in Push for Higher Returns Saregama India Draws Market Attention After Media Spotlight on Media and Entertainment Sector Apples AI Journey From Laggard to Potential Winner in the Generative AI Race Govt Explores Air Force Transport for NEET Papers Amid Exam Leak Crisis CZFS Q1 2026 Earnings EPS Beats Estimates by Nearly 7 But Stock Slips Beyond Air Inc XAIR Q1 2026 Earnings Narrowing Losses but Revenue Remains Absent 374Water Inc SCWO Q1 2026 Earnings Narrowing Losses and Commercial Progress Highlight a Quarter of Transition OXM Q1 2026 Earnings A Significant Earnings Miss Amid Strategic Adjustments Ascent Industries Co Q1 2025 Earnings EPS Misses Estimates Significantly Stock Declines RDI Q3 2025 Earnings Significant EPS Miss Highlights Operational Challenges Allied Gaming Entertainment AGAE Slips 367 as Stock Tests Key Support at 056 Asana Stock Slides Amid Weakening Momentum Key Levels to Watch ABVC BioPharma Consolidates at 139 as Support and Resistance Levels Narrow Rectitude Holdings RECT Tests Key Support After 366 Decline Gladstone Commercial Preferred Stock GOODN Shows Minimal Change Amid Tight Trading Range The Escalating 8 Billion Long COVID Crisis Rising Costs Amidst Federal Retreat AEVA Q1 2026 Earnings Narrower Loss Beats Expectations Shares Slide RTX Dips 13 as Defense Sector Faces Headwinds Key Support Levels in Focus AM Q1 2026 Earnings EPS Misses Estimates Stock Declines 149 GameStop GME Q1 2026 Earnings EPS Surges Past Estimates on Cost Discipline Revenue Remains Undisclosed PRH Q1 2026 Earnings Strong EPS Surge of 1539 on Solid Operational Performance RCUS Q1 2026 Earnings WiderthanExpected Loss Highlights Ongoing Biotech Development Costs Outset Medical Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher KPRX Q1 2026 Earnings NarrowerthanExpected Loss Fails to Lift Shares PHGE Q4 2025 Earnings Severe EPS Miss as BiomX Continues Clinical Development